Deoxyribonucleic acid (DNA) alkylation sites (DNA)

Deoxyribonucleic acid (DNA) alkylation sites are specific nucleophilic positions within the DNA polymer, most notably the N7 and O6 positions of guanine, that are targeted for covalent modification by alkylating agents. These sites are critical in oncology as the formation of DNA adducts at these locations disrupts the structural integrity and functional capacity of the genome. When alkylating drugs attach alkyl groups to these sites, they facilitate the formation of intra-strand and inter-strand cross-links, which physically prevent the DNA double helix from unwinding during replication and transcription. This mechanical blockade induces DNA damage responses and cell cycle arrest, ultimately leading to programmed cell death (apoptosis) in highly proliferative cancer cells. Despite their therapeutic utility, the non-specific nature of DNA alkylation in healthy cells poses risks of mutagenicity, teratogenicity, and the development of secondary malignancies.

Other names

DNA adductsNucleophilic DNA sitesAlkylated DNAGuanine N7 alkylation siteGuanine O6 alkylation site

Alkylating agents work by three primary mechanisms: 1) attachment of alkyl groups to DNA bases (most commonly at the N7 position of guanine), which leads to DNA fragmentation by repair enzymes; 2) formation of intra-strand and inter-strand cross-links that prevent DNA strand separation for replication or transcription; and 3) induction of nucleotide mispairing, which results in permanent mutations. These actions collectively trigger cell cycle arrest and apoptosis in rapidly dividing cells.